Potential health risks of complementary alternative medicines in cancer patients

被引:153
|
作者
Werneke, U
Earl, J
Seydel, C
Horn, O
Crichton, P
Fannon, D
机构
[1] Homerton Hosp, Dept Psychiat, London E9 6SR, England
[2] Inst Psychiat, Ctr Econ Mental Hlth, London SE5 8AJ, England
[3] Royal Marsden Hosp, Dept Pharm, Sutton SM2 5PT, Surrey, England
[4] Univ London Kings Coll, Sch Med & Dent, Acad Dept Psychol Med, London SE5 8AF, England
[5] Inst Psychiat, London SE5 8AF, England
[6] Royal Marsden Hosp, Dept Psychol Med, Sutton SM2 5PT, Surrey, England
[7] Maudsley Hosp & Inst Psychiat, London SE5 8AZ, England
[8] Inst Psychiat, Div Psychol Med, London SE5 8AZ, England
关键词
complementary alternative medicines; herbal remedies; supplements; cancer; risks; echinacea;
D O I
10.1038/sj.bjc.6601560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [1] Potential health risks of complementary alternative medicines in cancer patients
    U Werneke
    J Earl
    C Seydel
    O Horn
    P Crichton
    D Fannon
    [J]. British Journal of Cancer, 2004, 90 : 408 - 413
  • [2] Potential health risks of complementary alternative medicines in HIV patients
    Ladenheim, D.
    Horn, O.
    Werneke, U.
    Phillpot, M.
    Murungi, A.
    Theobald, N.
    Orkin, C.
    [J]. HIV MEDICINE, 2008, 9 (08) : 653 - 659
  • [3] Assessing health risks of complementary alternative medicines in cancer patients
    Shia, G
    Shaw, D
    Dargan, PI
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 995 - 996
  • [4] Assessing health risks of complementary alternative medicines in cancer patients
    G Shia
    D Shaw
    P I Dargan
    [J]. British Journal of Cancer, 2004, 91 : 995 - 996
  • [5] Reply: Assessing health risks of complementary alternative medicines in cancer patients
    U Werneke
    J Earl
    C Seydel
    O Horn
    P Crichton
    D Fannon
    [J]. British Journal of Cancer, 2004, 91 : 996 - 997
  • [6] Reply: Assessing health risks of complementary alternative medicines in cancer patients
    Werneke, U
    Earl, J
    Seydel, C
    Horn, O
    Crichton, P
    Fannon, F
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 996 - 997
  • [7] Complementary and alternative medicines in cancer patients
    Bosacki, Claire
    Vallard, Alexis
    Gras, Mathilde
    Daguenet, Elisabeth
    Morisson, Stephanie
    Mery, Benoite
    Jmour, Omar
    Guy, Jean-Baptiste
    Magne, Nicolas
    [J]. BULLETIN DU CANCER, 2019, 106 (05) : 479 - 491
  • [8] Complementary and alternative medicines taken by cancer patients
    Simon, L.
    Prebay, D.
    Beretz, A.
    Bagot, J-L
    Lobstein, A.
    Rubinstein, I.
    Schraub, S.
    [J]. BULLETIN DU CANCER, 2007, 94 (05) : 483 - 488
  • [9] Patients use complementary and alternative medicines
    Kerr, C
    [J]. LANCET ONCOLOGY, 2005, 6 (11): : 832 - 832
  • [10] Patients use complementary and alternative medicines
    Kerr, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (18) : 2781 - 2781